|
Volumn 21, Issue 18, 2000, Pages 1537-1546
|
Effect of 48-h intravenous trimetazidine on short- and long-term outcomes of patients with acute myocardial infarction, with and without thrombolytic therapy: A double-blind, placebo-controlled, randomized trial
a a a a a a a a a a a a a a a a a a a a more.. |
Author keywords
Free radicals; Myocardial infarction; Randomized controlled trial; Thrombolysis; Trimetazidine
|
Indexed keywords
ALTEPLASE;
ANISTREPLASE;
FIBRINOLYTIC AGENT;
FREE RADICAL;
PLACEBO;
STREPTOKINASE;
TRIMETAZIDINE;
UROKINASE;
ACUTE HEART INFARCTION;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
FEMALE;
FIBRINOLYTIC THERAPY;
FOLLOW UP;
HUMAN;
INTERMETHOD COMPARISON;
MAJOR CLINICAL STUDY;
MALE;
MORTALITY;
MULTICENTER STUDY;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
ADULT;
AGED;
CHI-SQUARE DISTRIBUTION;
DOUBLE-BLIND METHOD;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
MYOCARDIAL INFARCTION;
PROPORTIONAL HAZARDS MODELS;
PROSPECTIVE STUDIES;
SURVIVAL ANALYSIS;
THROMBOLYTIC THERAPY;
TREATMENT OUTCOME;
TRIMETAZIDINE;
VASODILATOR AGENTS;
|
EID: 0033817242
PISSN: 0195668X
EISSN: None
Source Type: Journal
DOI: 10.1053/euhj.1999.2439 Document Type: Article |
Times cited : (107)
|
References (17)
|